|
1
|
Nguyen Y and Sperandio V:
Enterohemorrhagic E. coli (EHEC) pathogenesis. Front Cell
Infect Microbiol. 2(90)2012.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Jones NL, Islur A, Haq R, Mascarenhas M,
Karmali MA, Perdue MH, Zanke BW and Sherman PM: Escherichia
coli Shiga toxins induce apoptosis in epithelial cells that is
regulated by the Bcl-2 family. Am J Physiol Gastrointest Liver
Physiol. 278:G811–G819. 2000.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Hughes AK, Stricklett PK, Schmid D, Kohan
DE and Hughes AK: Cytotoxic effect of Shiga toxin-1 on human
glomerular epithelial cells. Kidney Int. 57:2350–2359.
2000.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Rutjes NW, Binnington BA, Smith CR,
Maloney MD and Lingwood CA: Differential tissue targeting and
pathogenesis of verotoxins 1 and 2 in the mouse animal model.
Kidney Int. 62:832–845. 2002.PubMed/NCBI View Article : Google Scholar
|
|
5
|
O'Brien AD and Holmes RK: Shiga and
Shiga-like toxins. Microbiol Rev. 51:206–220. 1987.PubMed/NCBI
|
|
6
|
Karmali MA, Steele BT, Petric M and Lim C:
Sporadic cases of haemolytic-uraemic syndrome associated with
faecal cytotoxin and cytotoxin-producing Escherichia coli in
stools. Lancet. 1:619–620. 1983.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Yoshimitsu M, Hayashi N, Kaneko Y and
Doyama H: An adult case of combined encephalopathy and hemolytic
uremic syndrome caused by Escherichia coli O157. Nihon
Shokakibyo Gakkai Zasshi. 108:74–79. 2011.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gyles CL: Shiga toxin-producing
Escherichia coli: An overview. J Anim Sci. 85
(Suppl):E45–E62. 2007.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Remis RS, MacDonald KL, Riley LW, Puhr ND,
Wells JG, Davis BR, Blake PA and Cohen ML: Sporadic cases of
hemorrhagic colitis associated with Escherichia coli
O157:H7. Ann Intern Med. 101:624–626. 1984.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Fukushima H, Hashizume T, Morita Y, Tanaka
J, Azuma K, Mizumoto Y, Kaneno M, Matsuura M, Konma K and Kitani T:
Clinical experiences in Sakai City Hospital during the massive
outbreak of enterohemorrhagic Escherichia coli O157
infections in Sakai City, 1996. Pediatr Int. 41:213–217.
1999.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Terajima J, Izumiya H, Wada A, Tamura K
and Watanabe H: Shiga toxin-producing Escherichia coli
O157:H7 in Japan. Emerg Infect Dis. 5:301–302. 1999.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Wang O, McAllister TA, Plastow G, Stanford
K, Selinger B and Guan LL: Interactions of the Hindgut
Mucosa-Associated Microbiome with Its Host Regulate Shedding of
Escherichia coli O157:H7 by Cattle. Appl Environ Microbiol.
84(pii): e01738–17. 2017.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Ley RE, Bäckhed F, Turnbaugh P, Lozupone
CA, Knight RD and Gordon JI: Obesity alters gut microbial ecology.
Proc Natl Acad Sci USA. 102:11070–11075. 2005.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Momose Y, Hirayama K and Itoh K: Effect of
organic acids on inhibition of Escherichia coli O157:H7
colonization in gnotobiotic mice associated with infant intestinal
microbiota. Antonie van Leeuwenhoek. 93:141–149. 2008.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Yoshimura K, Matsui T and Itoh K:
Prevention of Escherichia coli O157:H7 infection in
gnotobiotic mice associated with Bifidobacterium strains.
Antonie van Leeuwenhoek. 97:107–117. 2010.PubMed/NCBI View Article : Google Scholar
|
|
16
|
de Sablet T, Chassard C,
Bernalier-Donadille A, Vareille M, Gobert AP and Martin C: Human
microbiota-secreted factors inhibit shiga toxin synthesis by
enterohemorrhagic Escherichia coli O157:H7. Infect Immun.
77:783–790. 2009.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Momose Y, Hirayama K and Itoh K:
Antagonism of intestinal bacteria isolated from human infants
against Escherichia coli O157:H7 infection in gnotobiotic
mice. Microb Ecol Health Dis. 17:9–14. 2005. View Article : Google Scholar
|
|
18
|
Asahara T, Shimizu K, Nomoto K, Hamabata
T, Ozawa A and Takeda Y: Probiotic bifidobacteria protect mice from
lethal infection with Shiga toxin-producing Escherichia coli
O157:H7. Infect Immun. 72:2240–2247. 2004.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chen YP, Lee TY, Hong WS, Hsieh HH and
Chen MJ: Effects of Lactobacillus kefiranofaciens M1
isolated from kefir grains on enterohemorrhagic Escherichia
coli infection using mouse and intestinal cell models. J Dairy
Sci. 96:7467–7477. 2013.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Rund SA, Rohde H, Sonnenborn U and
Oelschlaeger TA: Antagonistic effects of probiotic Escherichia
coli Nissle 1917 on EHEC strains of serotype O104:H4 and
O157:H7. Int J Med Microbiol. 303:1–8. 2013.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Eaton KA, Honkala A, Auchtung TA and
Britton RA: Probiotic Lactobacillus reuteri ameliorates
disease due to enterohemorrhagic Escherichia coli in
germfree mice. Infect Immun. 79:185–191. 2011.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Ogawa M, Shimizu K, Nomoto K, Takahashi M,
Watanuki M, Tanaka R, Tanaka T, Hamabata T, Yamasaki S and Takeda
Y: Protective effect of Lactobacillus casei strain Shirota
on Shiga toxin-producing Escherichia coli O157:H7 infection
in infant rabbits. Infect Immun. 69:1101–1108. 2001.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Fukuda S, Toh H, Hase K, Oshima K,
Nakanishi Y, Yoshimura K, Tobe T, Clarke JM, Topping DL, Suzuki T,
et al: Bifidobacteria can protect from enteropathogenic infection
through production of acetate. Nature. 469:543–547. 2011.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Food and Agriculture Organization of
United Nations and World Health Organization Working Group Report:
Guidelines for the evaluation of probiotics in food. FAO/WHO,
London, ON, 2002.
|
|
25
|
Resta-Lenert S and Barrett KE: Live
probiotics protect intestinal epithelial cells from the effects of
infection with enteroinvasive Escherichia coli (EIEC). Gut.
52:988–997. 2003.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Shreiner AB, Kao JY and Young VB: The gut
microbiome in health and in disease. Curr Opin Gastroenterol.
31:69–75. 2015.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Macpherson AJ and Harris NL: Interactions
between commensal intestinal bacteria and the immune system. Nat
Rev Immunol. 4:478–485. 2004.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Frick JS, Schenk K, Quitadamo M, Kahl F,
Köberle M, Bohn E, Aepfelbacher M and Autenrieth IB:
Lactobacillus fermentum attenuates the
proinflammatory effect of Yersinia enterocolitica on human
epithelial cells. Inflamm Bowel Dis. 13:83–90. 2007.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Kang HJ and Im SH: Probiotics as an Immune
Modulator. J Nutr Sci Vitaminol (Tokyo). 61 (Suppl):S103–S105.
2015.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Mariat D, Firmesse O, Levenez F, Guimarăes
V, Sokol H, Doré J, Corthier G and Furet JP: The
Firmicutes/Bacteroidetes ratio of the human microbiota changes with
age. BMC Microbiol. 9(123)2009.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Border M, Firehammer BD, Shoop DS and
Myers LL: Isolation of Bacteroides fragilis from the feces
of diarrheic calves and lambs. J Clin Microbiol. 21:472–473.
1985.PubMed/NCBI
|
|
32
|
Kim JM, Lee JY and Kim YJ: Inhibition of
apoptosis in Bacteroides fragilis enterotoxin-stimulated
intestinal epithelial cells through the induction of c-IAP-2. Eur J
Immunol. 38:2190–2199. 2008.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Chen LA, Van Meerbeke S, Albesiano E,
Goodwin A, Wu S, Yu H, Carroll K and Sears C: Fecal detection of
enterotoxigenic Bacteroides fragilis. Eur J Clin Microbiol
Infect Dis. 34:1871–1877. 2015.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Onderdonk AB, Bronson R and Cisneros R:
Comparison of Bacteroides vulgatus strains in the
enhancement of experimental ulcerative colitis. Infect Immun.
55:835–836. 1987.PubMed/NCBI
|
|
35
|
Rashidan M, Azimirad M, Alebouyeh M,
Ghobakhlou M, Asadzadeh Aghdaei H and Zali MR: Detection of B.
fragilis group and diversity of bft enterotoxin and antibiotic
resistance markers cepA, cfiA and nim among intestinal
Bacteroides fragilis strains in patients with inflammatory
bowel disease. Anaerobe. 50:93–100. 2018.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Mazmanian SK, Liu CH, Tzianabos AO and
Kasper DL: An immunomodulatory molecule of symbiotic bacteria
directs maturation of the host immune system. Cell. 122:107–118.
2005.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Riley LW, Remis RS, Helgerson SD, McGee
HB, Wells JG, Davis BR, Hebert RJ, Olcott ES, Johnson LM, Hargrett
NT, et al: Hemorrhagic colitis associated with a rare
Escherichia coli serotype. N Engl J Med. 308:681–685.
1983.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Li J, Mandal G and Rosen BP: Expression of
arsenic resistance genes in the obligate anaerobe Bacteroides
vulgatus ATCC 8482, a gut microbiome bacterium. Anaerobe.
39:117–123. 2016.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Cohen E, Ophir I and Shaul YB: Induced
differentiation in HT29, a human colon adenocarcinoma cell line. J
Cell Sci. 112 (Pt 16):2657–2666. 1999.PubMed/NCBI
|
|
40
|
Kuroda K, Fukuda T, Krstic-Demonacos M,
Demonacos C, Okumura K, Isogai H, Hayashi M, Saito K and Isogai E:
miR-663a regulates growth of colon cancer cells, after
administration of antimicrobial peptides, by targeting CXCR4-p21
pathway. BMC Cancer. 17(33)2017.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Isogai E, Isogai H, Kimura K, Hayashi S,
Kubota T, Fujii N and Takeshi K: Role of tumor necrosis factor
alpha in gnotobiotic mice infected with an Escherichia coli
O157:H7 strain. Infect Immun. 66:197–202. 1998.PubMed/NCBI
|
|
42
|
Koopman G, Reutelingsperger CP, Kuijten
GA, Keehnen RM, Pals ST and van Oers MH: Annexin V for flow
cytometric detection of phosphatidylserine expression on B cells
undergoing apoptosis. Blood. 84:1415–1420. 1994.PubMed/NCBI
|
|
43
|
Zelenin AV, Poletaev AI, Stepanova NG,
Barsky VE, Kolesnikov VA, Nikitin SM, Zhuze AL and Gnutchev NV:
7-Amino-actinomycin D as a specific fluorophore for DNA content
analysis by laser flow cytometry. Cytometry. 5:348–354.
1984.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Eaton KA, Fontaine C, Friedman DI, Conti N
and Alteri CJ: Pathogenesis of colitis in germ-free mice infected
with EHEC O157:H7. Vet Pathol. 54:710–719. 2017.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Bamba T, Matsuda H, Endo M and Fujiyama Y:
The pathogenic role of Bacteroides vulgatus in patients with
ulcerative colitis. J Gastroenterol. 30 (Suppl 8):45–47.
1995.PubMed/NCBI
|
|
46
|
Frankel G, Phillips AD, Rosenshine I,
Dougan G, Kaper JB and Knutton S: Enteropathogenic and
enterohaemorrhagic Escherichia coli: More subversive
elements. Mol Microbiol. 30:911–921. 1998.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Pifer R and Sperandio V: The interplay
between the microbiota and enterohemorrhagic Escherichia
coli. Microbiol Spectr. 2:2014.PubMed/NCBI View Article : Google Scholar
|
